Publication | Closed Access

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

Interferon β-1ADouble-blind Placebo-controlled StudyAutoimmune DiseaseNeurological DisorderMedicineImmunologyClinical TrialsClinical NeurologyNeurological ProgressNeurologyMultiple SclerosisNeuroimmunology